About Firm News
In the News
K&S Advises Novanta on $1.45B Acquisition of Riverpoint Medical
June 9, 2026
| Law360, PE Hub, Mergers & Acquisitions, S&P Global and The Deal
Featured Lawyers:
Person Jessica Ringel
Jessica Ringel
Partner
Person Joseph Eisert
Joseph A. Eisert
Partner
Person Douglas Henderson
Douglas A. Henderson
Partner
Person Mark Brown
Mark S. Brown
Partner

K&S advises Novanta on its $1.45B acquisition of medical device maker Riverpoint Medical from Arlington Capital Partners.

Third-party coverage:

Novanta Buys Riverpoint In $1.45B Deal Steered By 3 Firms (Law360)

Arlington to sell medical device firm Riverpoint Medical for $1.2bn (PE Hub) [behind a paywall]

Novanta buys Riverpoint Medical from Arlington Capital Partners (Mergers & Acquisitions)

Data center boom fuels renewables deals; AI drives corporate venture investment (S&P Global)

Deal Diary: Goodwin Helps Arlington Take Riverpoint From Buyout to Sale (The Deal) [behind a paywall]

Related Capabilities
Environmental, Health & Safety FDA & Life Sciences Environmental Litigation Life Sciences & Healthcare Manufacturing Pharmaceutical & Medical Device
Featured Lawyers
Person Jessica Ringel
Jessica Ringel
Partner
Government Matters & Regulation
Person Joseph Eisert
Joseph A. Eisert
Partner
Government Matters & Regulation
Person Douglas Henderson
Douglas A. Henderson
Partner
Government Matters & Regulation
Person Mark Brown
Mark S. Brown
Partner
Government Matters & Regulation